Get the Stockscreener App
24.66
1.73%
0.42
After Hours:
24.66
Amphastar Pharmaceuticals Inc stock is traded at $24.66, with a volume of 390.80K.
It is up +1.73% in the last 24 hours and down -8.40% over the past month.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
See More
Previous Close:
$24.24
Open:
$24.24
24h Volume:
390.80K
Relative Volume:
0.81
Market Cap:
$1.15B
Revenue:
$722.68M
Net Income/Loss:
$134.71M
P/E Ratio:
9.236
EPS:
2.67
Net Cash Flow:
$109.94M
1W Performance:
-0.24%
1M Performance:
-8.40%
6M Performance:
+0.65%
1Y Performance:
-51.44%
1-Day Range:
$24.02
$24.81
1-Week Range:
$23.77
$24.89
52-Week Range:
$20.39
$53.95
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Name
Amphastar Pharmaceuticals Inc
Sector
Phone
909-980-9484
Address
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Compare AMPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
24.66 | 1.13B | 722.68M | 134.71M | 109.94M | 2.67 |
|
ZTS
Zoetis Inc
|
144.10 | 63.79B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.23 | 43.49B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.18 | 40.30B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 23.21B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
453.53 | 20.59B | 3.08B | 1.24B | 1.07B | 25.61 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-25 | Upgrade | Needham | Hold → Buy |
| May-12-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-04-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Nov-22-24 | Initiated | Wells Fargo | Equal Weight |
| Mar-05-24 | Initiated | JP Morgan | Overweight |
| Nov-17-23 | Initiated | BofA Securities | Neutral |
| Jul-25-23 | Resumed | Jefferies | Buy |
| Oct-21-22 | Resumed | Jefferies | Buy |
| Jul-29-22 | Initiated | CapitalOne | Overweight |
| Jan-07-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-08-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-05-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| May-01-20 | Initiated | Northland Capital | Outperform |
| Mar-13-19 | Downgrade | Needham | Buy → Hold |
| Mar-13-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Aug-10-18 | Reiterated | Needham | Buy |
| Mar-13-18 | Reiterated | Needham | Buy |
| Dec-01-17 | Reiterated | Needham | Buy |
| Nov-09-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-27-17 | Reiterated | Needham | Buy |
| Mar-14-17 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-09-16 | Reiterated | Needham | Buy |
| May-10-16 | Reiterated | Needham | Buy |
| Feb-19-16 | Initiated | Wells Fargo | Outperform |
| Jun-19-15 | Reiterated | Needham | Buy |
| Jun-03-15 | Initiated | Raymond James | Strong Buy |
| Jul-21-14 | Initiated | Needham | Buy |
View All
Amphastar Pharmaceuticals Inc Stock (AMPH) Latest News
Can Amphastar Pharmaceuticals Inc. stock maintain growth trajectoryJuly 2025 Sector Moves & Stepwise Trade Execution Plans - newser.com
Analyzing recovery setups for Amphastar Pharmaceuticals Inc. investors2025 Geopolitical Influence & Low Risk High Win Rate Picks - newser.com
Will Amphastar Pharmaceuticals Inc. (29A) stock outperform energy sector in 2025Swing Trade & Reliable Volume Spike Alerts - newser.com
How Amphastar’s New BAQSIMI Distribution Pact in Greater China Could Impact AMPH Investors - Yahoo Finance
Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Can Amphastar Pharmaceuticals Inc. stock hit analyst price targetsWeekly Profit Analysis & Stock Portfolio Risk Management - newser.com
Can trapped investors hope for a rebound in Amphastar Pharmaceuticals Inc.Insider Selling & Free Expert Verified Stock Movement Alerts - newser.com
Real time scanner hits for Amphastar Pharmaceuticals Inc. explainedJuly 2025 Review & Fast Gain Stock Tips - newser.com
Will Amphastar Pharmaceuticals Inc. stock deliver shareholder value2025 Volume Leaders & Daily Risk Controlled Trade Plans - newser.com
Is Amphastar Pharmaceuticals Inc. (29A) stock trading at attractive multiplesJuly 2025 Catalysts & Community Verified Swing Trade Signals - newser.com
What momentum shifts mean for Amphastar Pharmaceuticals Inc.Weekly Profit Summary & AI Optimized Trade Strategies - newser.com
Why Amphastar Pharmaceuticals Inc. stock remains resilientJuly 2025 Snapshot & Reliable Intraday Trade Alerts - newser.com
Key metrics from Amphastar Pharmaceuticals Inc.’s quarterly data2025 Key Highlights & Precise Buy Zone Tips - newser.com
Multi asset correlation models including Amphastar Pharmaceuticals Inc.Dollar Strength & Weekly Top Performers Watchlists - newser.com
Why Amphastar Pharmaceuticals Inc. (29A) stock could be next leader2025 Market Sentiment & Stepwise Entry and Exit Trade Signals - newser.com
Is Amphastar Pharmaceuticals Inc. (29A) stock a buy for dividend portfoliosPortfolio Return Report & Low Risk High Win Rate Picks - newser.com
Using Python tools to backtest Amphastar Pharmaceuticals Inc. strategiesWeekly Profit Analysis & Free Daily Entry Point Trade Alerts - newser.com
Should you wait for a breakout in Amphastar Pharmaceuticals Inc.Portfolio Risk Summary & Real-Time Market Sentiment Reports - newser.com
United States Anaphylaxis Treatment Market 2025: Industry - openPR.com
Applying Elliott Wave Theory to Amphastar Pharmaceuticals Inc.July 2025 Earnings & Precise Buy Zone Identification - newser.com
Why Amphastar Pharmaceuticals Inc. stock attracts high net worth investorsWatch List & Safe Entry Trade Reports - Fundação Cultural do Pará
Amphastar Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
AlphaQuest LLC Acquires 17,289 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Will Amphastar Pharmaceuticals Inc. (29A) stock beat international competitionWeekly Loss Report & Free Low Drawdown Momentum Trade Ideas - newser.com
How strong is Amphastar Pharmaceuticals Inc. stock balance sheetPortfolio Return Summary & Weekly Top Performers Watchlists - Fundação Cultural do Pará
Is Amphastar Pharmaceuticals Inc. (29A) stock good for long term investingJuly 2025 Gainers & Consistent Income Trade Ideas - newser.com
How Amphastar Pharmaceuticals Inc. stock responds to policy changesQuarterly Performance Summary & Real-Time Chart Pattern Alerts - Fundação Cultural do Pará
Amphastar Pharmaceuticals Inc Stock (AMPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.51%
0.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):